Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to determine the effect of Coenzyme Q10 supplementation on conventional therapy of children with heart failure due to idiopathic dilated cardiomyopathy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tehran
• Treatments: Coenzyme Q10; Ubiquinone

Criteria

Inclusion Criteria:

• Known cases of Idiopathic Dilated Cardiomyopathy (IDC)

• Those patients in whom heart failure medications were stable for at least 1 month

• More than 6 months aged

Exclusion Criteria:

• Recent modification in medications

• Hemodynamic instability

• Congenital heart disease

• Metabolic heart disease

• Cardiac dysfunction resulting from abnormalities in other organs and those with an acquired cardiomyopathy